Dr. Anna Brook Bahnson, MD

Dr. Bahnson practices at Avera Medical Group Dermatology - HOPD in Sioux Falls, South Dakota.

Dr. Bahnson's NPI, 1073177853, was assigned on April 26, 2019. Dr. Bahnson holds South Dakota license 14526.

Dr. Bahnson's primary practice is Avera Medical Group Dermatology - HOPD, at 6701 S Minnesota Ave, Sioux Falls, SD 57108.

Dr. Bahnson's primary practice is Avera Medical Group Dermatology - HOPD in Sioux Falls, South Dakota. Dr. Bahnson is also affiliated with Avera McKennan Hospital & University Health Center. The medical group on file is Avera McKennan Hospital & University Health Center. Dmand AI also links Dr. Bahnson to 1 more group practice or clinic, named with a free account. Dr. Bahnson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bahnson practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bahnson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bahnson is licensed in South Dakota.

CMS data shows 1,352 Medicare services from Dr. Bahnson across 10 procedure codes in 2024, for 396 Medicare patients. Medicare paid $38,694 for them. Every service was in an office.

CMS counts 396 Medicare patients who saw Dr. Bahnson in 2024. The largest group is 65 to 74, with 230 patients. 69% of them have high cholesterol, and 64% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bahnson's median patient age at 63, with 64% women.

In 2024, Dr. Bahnson wrote 579 Medicare Part D claims for 211 patients. 89% of them were for generic drugs. CMS names the drug for 467 of them, across 16 drugs with 11 or more claims each, at $161,345 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

Dr. Bahnson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 433 procedures of removal of skin lesions by Dr. Bahnson, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Bahnson. The most frequent topics are Skin Neoplasms. Dr. Bahnson has published most often in S D Med. Dr. Bahnson's most frequent co-authors are Kayla Jean Riswold and Develyn Vetos.

CMS Open Payments shows 58 general payments to Dr. Bahnson from 14 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $649.